The VCB is the largest open access cancer biobank in Australia.

Our resources empower researchers and facilitates groundbreaking scientific discoveries. From uncovering potential cancer biomarkers, to revolutionary cancer detection technology and innovative cancer monitoring methods, the VCB has been instrumental in advancing the field and supporting people affected by cancer.


39,441 participants with 450,000 tissue and blood specimens readily available for research


Empowering Research

Our services have benefited over 300 research projects and over 100 clinical trials


Basic science


Biotechnology innovation

Beaker stand

Clinical trials


Personalised medicine


In 2022-23, 14,692 specimens have contributed to over 60 projects working on prevalent cancers (e.g. breast, bowel) and low-survival cancers (e.g. lung)


Some long-term users: CSIRO, Monash University, ONJCRI, Rhythm Biosciences, WEHI

Legal document

Established an MOU with Singapore Translational Cancer Consortium to foster cancer research collaboration


Contributing to novel innovation, such as:

Testing samples

ColoSTAT®: Easy blood test for bowel cancer


DYNAMIC studies: Development of ctDNA technology to monitor cancer treatment response in colorectal and pancreatic cancers

Blood sample

Novel ‘prick blood’ test for cancer monitoring under development by Universal Biosensors


330 Scientific publications


$1.59 return of Investment for every dollar invested in VCB


We supported researchers to secure funding of over $16 million in the past two years


Stories of our impact  View all

Through the generosity of the donations of thousands of Victorians, the VCB has been able to bridge the gap between research and real-world impact.

Basic Science research to discover potential cancer biomarker

Wednesday 21 December 2022
A new protein involved in breast cancer has been revealed by Dr Jeremy Drake (Victoria University) and a group of Australian and international collaborators.

Novel self-test for cancer monitoring - Tn Antigen 'blood prick' test

Wednesday 21 December 2022
Universal Biosensors, a Victorian based company, has obtained biospecimens from VCB for their international development clinical study. Their study aims to develop a handheld portable cancer biosensor for T and Tn Antigen using a “finger prick” blood test for measuring patient cancer remission and reoccurrence.

Supporting Bench to Bed Discovery – the Story of SubB2

Friday 10 December 2021
Professor Michael Jennings and his laboratory at Griffith University’s Institute of Glycomics, along with collaborators Prof James Patton and Prof A Patton at the University of Adelaide, have developed a novel technology for the early detection of various cancers including ovarian and breast cancer.


Share your story



The VCB is a critical infrastructure that provides vital resources for researchers to improve cancer outcomes, and we’re proud to support their pioneering work to change and save lives – it’s innovations like these that demonstrate why the Victorian Government’s investment in medical research is so critically important.

Honorary Ben Carroll, Minister for Medical Research

Victorian Government


The support provided by the VCB, which included recruitment and provision of high-quality blood samples from donor participants, was instrumental for the foundational biomarker discovery and development work that we undertook at CSIRO, which has been critical for commercial success.

Dr Kim Fung, Principal Research Scientist



The support provided by the VCB, its staff, and its network of hospitals, and in particular the generosity of its sample donors, have all been critical in enabling the great progress that our company has made in developing a new, simple, blood-based diagnostic test for the early detection of colorectal cancer and our other target cancers.”

Dr Trevor Lockett, Technical Director

Rhythm Biosciences


The Victorian Cancer Biobank through the Cancer Council Victoria as Lead Agency is supported by the Victorian Government through the Victorian Cancer Agency, a business unit of the Department of Health.

RAP Victorian Cancer Biobank would like to acknowledge the traditional custodians of the land on which we live and work. We would also like to pay respect to the elders past and present and extend that respect to all other Aboriginal people.

Jump to page top

Consortium members

Cancer Council Victoria Austin Health Eastern Health Monash Health Peter Mac Royal Melbourne Hospital

Supported by